Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jul 21:2022:8156942.
doi: 10.1155/2022/8156942. eCollection 2022.

Recurrence of LV Thrombus in a Patient with Severe Ischaemic Cardiomyopathy Anticoagulated with Apixaban

Affiliations
Case Reports

Recurrence of LV Thrombus in a Patient with Severe Ischaemic Cardiomyopathy Anticoagulated with Apixaban

Azhar Farooqui et al. Case Rep Cardiol. .

Abstract

Background: Anticoagulation with warfarin remains the mainstay treatment for left ventricular thrombi. Although successful thrombus resolution has been reported with direct oral anticoagulants' (DOACs') recurrence/progression while resuming Apixaban therapy is yet to be reported. Case Presentation. This case report describes left ventricular thrombus progression/recurrence in a patient anticoagulated with Apixaban undergoing implantable cardioverter defibrillator to cardiac resynchronisation therapy with defibrillator upgrade procedure. He was thereafter changed to warfarin. Contrast echocardiogram at 6 months follow-up did not identify the previously demonstrated mural thrombus.

Conclusion: Prospective randomised control trials should be conducted in patients with left ventricular thrombus to compare anticoagulants, assess the efficacy and safety of DOACs, and evaluate uninterrupted DOAC versus transient withdrawal for cardiac device procedures.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Delayed enhanced cardiac magnetic resonance image. Delayed enhanced cardiac MR (CMR) demonstrating an apical laminar thrombus (blocked arrow).
Figure 2
Figure 2
Post device upgrade ECHO. (a) Parasternal short axis view and (b) apical 4-chamber view of transthoracic echocardiogram demonstrating the left ventricular apical thrombus (arrow).
Figure 3
Figure 3
Contrast-enhanced transthoracic echocardiogram. Contrast ECHO demonstrating the left ventricular thrombus.

References

    1. Garber A. M., Mentz R. J., Al-khalidi H., Shaw L. K., Fiuzat M., O'connor C. Clinical predictors and outcomes of patients with left ventricular thrombus following ST-segment elevation myocardial infarction. Journal of Thrombosis and Thrombolysis . 2016;41(3):365–373. doi: 10.1007/s11239-015-1252-0. - DOI - PubMed
    1. McCarthy C. P., Murphy S., Venkateswaran R. V., et al. Left ventricular thrombus: contemporary etiologies, treatment strategies, and outcomes. Treatment Strategies, and Outcomes, JACC . 2019;73(15):2007–2009. doi: 10.1016/j.jacc.2019.01.031. - DOI - PubMed
    1. Crawford T. C., Smith W. T., IV, Velazquez E. J., Taylor S. M., Jollis J. G., Kisslo J. Prognostic usefulness of left ventricular thrombus by echocardiography in dilated cardiomyopathy in predicting stroke, transient ischemic attack, and death. American Chemical Journal . 2004;93(4):500–503. doi: 10.1016/j.amjcard.2003.10.056. - DOI - PubMed
    1. Lattuca B., Bouziri N., Kerneis M., et al. Antithrombotic therapy for patients with left ventricular mural thrombus. Journal of the American College of Cardiology . 2020;75(14):1676–1685. doi: 10.1016/j.jacc.2020.01.057. - DOI - PubMed
    1. Fleddermann A. M., Hayes C. H., Magalski A., Main M. L. Efficacy of Direct Acting Oral Anticoagulants in Treatment of Left Ventricular Thrombus. American Chemical Journal . 2019;124(3):367–372. doi: 10.1016/j.amjcard.2019.05.009. - DOI - PubMed

Publication types

LinkOut - more resources